Veru, Inc. is seeking emergency use authorization for its drug product. The company is scaling up its production of sabizabulin in advance of FDA approval to meet market demand as soon as possible.
UT’s contributions were recently recognized by AUTM’s Better World Project, which named the UT Research Foundation as its 2020 Legend Award honoree.
In a regional webinar hosted by the University of Tennessee System and Vanderbilt University, Kelvin Droegemeier, director of the White House Office of Science and Technology Policy, urged researchers to be aware of the pervasive threat by some foreign governments to the United States.
The Spark Innovation Center will help six fledgling tech companies identify marketplace needs, develop their technology solutions and build working prototypes.
A company with technology licensed from the UT Research Foundation secured $25 million to work on transformative medicines to improve the lives of patients with systemic amyloidosis.
